(Total Views: 352)
Posted On: 06/26/2025 2:41:48 AM
Post# of 154582
The dosage:
So NO patients got 700 mg. It also makes me wonder how long the treatment went on: "until progression" was one option. Could it be that continued treatment would have saved the other two patients who responded?
Quote:
Five mCRC patients received weekly subcutaneous leronlimab at initial doses of 350mg or 525mg until progression or unacceptable toxicity
So NO patients got 700 mg. It also makes me wonder how long the treatment went on: "until progression" was one option. Could it be that continued treatment would have saved the other two patients who responded?
(7)
(0)
